Viewing Study NCT01499368


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2026-02-25 @ 8:18 PM
Study NCT ID: NCT01499368
Status: COMPLETED
Last Update Posted: 2025-01-15
First Post: 2011-12-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
Sponsor: Boryung Pharmaceutical Co., Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: LAF-BR-CT-302
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators